Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial

Iris Baumgartner1, Lars Norgren2, F Gerry R Fowkes3

  • 1Swiss Cardiovascular Centre, Inselspital, Division of Angiology, Bern University Hospital, University of Bern, Bern, Switzerland.

Insights

Lower extremity revascularization (LER) in peripheral artery disease (PAD) patients increased risks for major cardiovascular events and major adverse limb events (MALE). Endovascular LER was most common, but both surgical and endovascular procedures carried significant risks.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Clinical Trials

Background:

  • Peripheral artery disease (PAD) management often involves lower extremity revascularization (LER).
  • Long-term outcomes and predictors of LER in PAD patients remain incompletely understood.
  • The EUCLID trial provides a platform to investigate LER outcomes in a large PAD cohort.

Purpose of the Study:

  • To analyze lower extremity revascularization (LER) in the EUCLID trial.
  • To identify predictors of LER in patients with peripheral artery disease (PAD).
  • To evaluate cardiovascular and limb-related outcomes following LER.

Main Methods:

  • Analysis of patients undergoing post-randomization LER (n=1,738) versus no LER (n=12,147) from the EUCLID trial.
  • Assessment of independent predictors for LER using univariable and multivariable models.
  • Primary endpoint: myocardial infarction, ischemic stroke, or cardiovascular death. Major adverse limb events (MALE): acute limb ischemia or major amputation.

Main Results:

  • Post-randomization LER occurred in 12.5% of patients, predominantly endovascular (74.7%).
  • Independent LER predictors included prior LER, geographic region, limb symptoms, diabetes, and smoking.
  • LER was associated with increased risk for primary endpoint (HR 1.60) and MALE (HR 12.0).

Conclusions:

  • Lower extremity revascularization (LER) in PAD patients, most often endovascular, is linked to higher risks of cardiovascular events and MALE.
  • Surgical LER showed numerically higher primary endpoint event rates, while MALE rates were similar between endovascular and surgical approaches.
  • These findings highlight the significant risks associated with LER in PAD patients, underscoring the need for careful consideration of treatment strategies.
Abstract

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.9K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.3K
Absolute and Local Extreme Values01:22

Absolute and Local Extreme Values

The highest and lowest values of a function, relative to a reference axis, are known as extreme values. These include absolute maximum and absolute minimum values, which represent the highest and lowest points the function reaches across its entire domain. Within a restricted portion of the function, the highest and lowest values are referred to as local maximum and local minimum values, respectively.Periodic functions, such as sine and cosine, show extreme values at infinitely many points due...
77